BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21933150)

  • 1. Aplasia Ras homologue member I overexpression induces apoptosis through inhibition of survival pathways in human hepatocellular carcinoma cells in culture and in xenograft.
    Pei XH; Yang Z; Liu HX; Qiao SS
    Cell Biol Int; 2011 Oct; 35(10):1019-24. PubMed ID: 21933150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.
    Zhao X; Li J; Zhuo J; Cai L
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):417-21. PubMed ID: 21093415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
    Lu X; Qian J; Yu Y; Yang H; Li J
    Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
    Gong K; Li W
    Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways.
    Zhao B; Ma Y; Xu Z; Wang J; Wang F; Wang D; Pan S; Wu Y; Pan H; Xu D; Liu L; Jiang H
    Cancer Lett; 2014 May; 347(1):79-87. PubMed ID: 24486741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity.
    Hu YQ; Si LJ; Ye ZS; Lin ZH; Zhou JP
    Mol Med Rep; 2013 Apr; 7(4):1180-4. PubMed ID: 23447002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
    Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma.
    Yan TD; Wu H; Zhang HP; Lu N; Ye P; Yu FH; Zhou H; Li WG; Cao X; Lin YY; He JY; Gao WW; Zhao Y; Xie L; Chen JB; Zhang XK; Zeng JZ
    Cancer Res; 2010 Mar; 70(6):2285-95. PubMed ID: 20197465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
    Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
    Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
    Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
    Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.